2024-517746-34-00招募中1 期
A phase I study of [68Ga]Ga-DWJ155 in patients with advanced breast and NSCLC cancers
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 36
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Novartis Pharma Arzneimittel GmbH
Scientific
Novartis Pharma AG
研究点 (1)
Loading locations...
相似试验
招募中
1 期
A phase I of TG6050 in the treatment of patients with metastatic lung cancer2024-513093-22-00Transgene36
已完成
2 期
A phase I study of [177Lu]Lu-FF58 in patients with advanced solid tumors2022-502367-37-00Novartis Pharma AG55
招募中
1 期
A Phase 1 study of GSK5764227 in participants with advanced solid tumors2024-513663-10-01Glaxosmithkline Research & Development Limited, Glaxosmithkline Research & Development Limited112
招募中
1 期
Phase I study of IAG933 in patients with advanced Mesothelioma and other solid tumors2023-508369-34-00Novartis Pharma AG89
已完成
不适用
Pilot Study – Use of [68Ga] gallium-labelled Prostate Specific Membrane Antigen (PSMA) Positron Emission Tomography (PET) for the Characterisation of Metastatic Lesions in Patients with Renal Cell CarcinomaACTRN12615000854538Dr Simon Wood10